Back
United Therapeutics Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
UTHR
United Therapeutics
Last Price:
$297.44
Seasonality Move:
7.07%
7 Day Trial
ALL ACCESS PASS
$
7
United Therapeutics Stock Forecast
-
Over the next 52 weeks, United Therapeutics has on average historically risen by 18.3% based on the past 26 years of stock performance.
-
United Therapeutics has risen higher in 16 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.54%
-
Is United Therapeutics Stock Undervalued?The current United Therapeutics [UTHR] share price is $298.16. The Score for UTHR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
UTHR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will United Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, United Therapeutics has on average historically risen by 18.3% based on the past 26 years of stock performance.
United Therapeutics Stock Rating
Sell
49
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics overpriced?
-
United Therapeutics has risen higher in 16 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.54%
United Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unither.com
52-Week Data
52-Week High:
417.82
52-Week Low:
266.98
Prediction Charts
Market Cap:
13.4B
Price in USD:
298.16
Volume:
324.8K
Beta:
0.52
Technical Analysis
SMA50:
301.00
SMA100:
304.39
SMA200:
334.81
52-Wk Change:
-9.15%
Stock Predictions
-
Is United Therapeutics stock public?Yes, United Therapeutics is a publicly traded company.
-
What is the United Therapeutics stock quote today?The United Therapeutics stock price is 298.16 USD today.
-
How to buy United Therapeutics stock online?You can buy United Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jun-26 | 288.20 | 284.09 | 288.99 | 283.52 |
| Jun-27 | 284.09 | 284.27 | 287.73 | 282.42 |
| Jun-30 | 285.75 | 287.35 | 290.00 | 284.39 |
| Jul-1 | 287.15 | 290.91 | 295.18 | 286.57 |
| Jul-2 | 290.08 | 295.22 | 295.98 | 290.08 |
| Jul-3 | 295.66 | 294.49 | 298.30 | 291.13 |
| Jul-7 | 294.30 | 290.39 | 294.30 | 286.68 |
| Jul-8 | 290.53 | 294.42 | 298.46 | 290.53 |
| Jul-9 | 296.80 | 300.56 | 300.91 | 295.30 |
| Jul-10 | 300.00 | 300.16 | 301.75 | 295.53 |
| Jul-11 | 298.19 | 295.52 | 298.96 | 295.33 |
| Jul-14 | 294.21 | 297.68 | 298.47 | 294.21 |
| Jul-15 | 297.70 | 293.24 | 300.37 | 291.72 |
| Jul-16 | 295.25 | 298.16 | 299.83 | 295.01 |
United Therapeutics Earnings
United Therapeutics Earnings Report: Per Share United Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
United Therapeutics Forecast Revenue Growth
United Therapeutics Stock Analysis: Historical quarterly revenues per share for United Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.78 per share, an increase next quarter of $0.76 per share, an increase this year of $2.42 per share, and an increase next year of $1.34 per share.
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.